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Abstract
Cardiovascular diseases (CVDs), ranked top non-communicable diseases 
(NCDs), are the second leading cause of mortality in Africa, especially in sub-
Saharan Africa (SSA) where they account for 73·4% global deaths and 80% of 
all premature deaths yearly. The ill-health due to CVDs in SSA is equivalent to 
the combined burden due to communicable, maternal, neonatal and nutritional 
diseases. Un-addressed, it is extrapolated that the Sustainable Development Goal 
3.4 which targets NCDs will not be achieved. The preponderance of CVDs in SSA is 
due to determinants such as the epidemiological transition of diseases, aging, stress, 
illiteracy, poor health systems and poverty. This is quite worrisome for SSA dubbed 
“one of the most poverty stricken region on the globe”. As such, poverty in Africa 
may adversely affect CVDs, but this has been less examined. This chapter explores 
the impact of poverty on CVDs and healthcare systems related to CVDs in Africa.
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1. Introduction
Cardiovascular diseases (CVDs) such as heart failure, cerebrovascular diseases, 
and ischemic heart diseases are major plaques in Africa. The burden of CVDs is 
high in Africa and particularly in sub-Saharan Africa (SSA) where the magnitude 
of CVDs is equivalent to the combined magnitude due to communicable, maternal, 
neonatal and nutritional diseases. In Africa the burden of CVDs, is partly flued by 
poverty which is often overlooked. This chapter discusses the impact of poverty on 
CVDs and healthcare systems related to CVDs in Africa.
2. Epidemiological transition and cardiovascular diseases in Africa
Epidemiological transition can be defined as the transition, under the influ-
ence of socio-economic development and aging, from predominantly infectious 
diseases to mainly chronic non-communicable diseases [1]. This concept was 
first introduced in the 1971’s by Omrad and Olshansky, and Ault later on refined 
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its meaning [2]. The transition process according to Omrad was in three ages or 
phases [2]: The age of pestilence and famine, the age of receding pandemics, and 
the age of degenerative and man-made diseases.
The age of pestilence and famine is characterized by a period of high infant and 
child mortality with a low mean life expectancy of less than 30 years. This stemmed 
from the high rate of malnutrition and infectious diseases or communicable disease 
like tuberculosis, pneumonia, and diarrheal diseases in Africa; with less than 10% 
of the mortality rate due to cardiovascular diseases [2, 3]. The age of receding 
pandemics is characterized by an improvement in public health policies and nutri-
tion patterns leading to a decrease in the rate of infant and child deaths from to 
malnutrition and infectious diseases. This decrease in mortality was accompanied 
by a rise in the life expectancy from 30 to 50 years or more [2, 3]. The age of degen-
erative and man-made diseases is marked by an excessive intake of fat and calories 
with a decrease in physical activity leading to the emergence of non-communicable 
diseases (NCDs) such as ischemic heart diseases and heart failure. An increase in 
life expectancy as a result of a reduction in the mortality rate of infectious or com-
municable diseases tremendously marked the age of degenerative and man-made 
diseases. On the other hand, there is a higher death rate shift in NCD, more specifi-
cally cardiovascular diseases (CVDs). The death rate due to CVDs varies between 35 
and 65% of the overall mortality rate [2, 3]. The challenges entail strengthening the 
prevention and improvement of the management of CVD.
Low- to middle-income countries (LMICs) in Sub-Saharan Africa (SSA) are 
of the epidemiological transition process [4]. A 20-year assessment of the disease 
burden in SSA between 1990 to 2010 shows a decline in premature mortality 
and disability attributable to neonatal, nutritional and maternal communicable 
diseases, including lower respiratory infections and diarrhoeal diseases [4]. It is 
worth mentioning that there were communicable diseases that occur permanently 
with the same high mortality rate over these 20 years-periods [4]. With only 12% 
of the world’s population in Africa, Africa bears a considerable proportion of the 
global burden of tuberculosis, HIV/AIDS and malaria with rates of 31%, 62% and 
70% respectively [5]. Besides communicable diseases, the disease burden due to 
NCDs is not trivial. Between 1990 to 2010, the disease burden from several NCDs 
increased, particularly stroke, depression, diabetes, and ischemic heart disease 
[4]. An assessment made in SSA from 1990 to 2017 shows a 67% growth in the total 
number of disability-adjusted lives (DALYS) due to NCDs (90.6 million in 1990 
and 151.3 million in 2017) [6]. The increment in NCDs in SSA was mainly flued by 
CVDs, ranked as the second leading cause of the NCD burden in 2017, resulting in 
22.9 (21.5–24.3) million DALYs (15.1% of the total NCD burden), after the group of 
disorders categorized as other NCDs (28.8 million [25.1–33.0] DALYs, 19.1%) [6]. 
This data show the progressive and increasing installation of NCDs in Africa and 
their impact on morbidity and mortality.
3. Poverty in Africa
Poverty is a multidimensional concept. According to the United Nations 
Development Programme (UNDP), poverty is not only the lack of income neces-
sary to meet food and non-food needs (clothing, energy, housing) but also a lack 
of basic human capabilities (illiteracy, malnutrition, reduced life expectancy, poor 
maternal health, illness) [7]. Therefore poverty should not be considered only 
under the spectrum of financial income; as a result, the concept of poverty is dif-
ficult to quantify. But for a global assessment of poverty, a monetary scale has been 
developed as a common denominator between the different regions of the world in 
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order to be able to assess poverty. According to the World Bank, the poverty line 
is considered to be 1.90 dollars per day per inhabitant since 2011 [8]. In 2015, the 
rate of the world’s population living in poverty was 10%, representing 736 million 
people, more than half of whom live in SSA, on less than US$1 a day [8, 9]. The 
advent of industrialization in China and India tremendously decreased the poverty 
rate unlike in SSA where progress in poverty has been limited. Of these 736 million 
poverty stricken population living on earth in 2015, 80% resided in SSA [10]. 
According to the World Bank’s estimates, the global poverty rate slightly dipped to 
8.6% in 2018. No isolated figure was reported for SSA. But since 2018, the World 
Bank has repeatedly reported that SSA will consistently record a poverty rate of 
at least two figures till the year 2030 unless very drastic interventions are put into 
place to address the problem of poverty in SSA [10].
In several SSA countries, the direct care costs, are high in relation to household 
income, a major factor in poverty. The cost of HIV/AIDS treatment for an adult, 
combined with the loss of income due to absence from work, can push an entire 
household below the poverty line. Therefore, just as good health can stimulate 
economic growth, poor health can lead to poverty from which it is very difficult to 
escape. The vicious cycle of poverty and poor health is observed in many African 
countries. About 76% of people in SSA have an income of less than US$2 per day 
and 46.5% have an income of less than US$1.08 per day [9]. While poverty has 
been declining in other parts of the world such as East and South Asia over the two 
decades the trend is clearly reversed in SSA. Between 1981 and 2001, the domestic 
product of SSA countries fell by 13% and the number of people in this region living 
on less than US$1 per day doubled from 164 million to 314 million. While Africans 
accounted for only 16% of the world’s poor population in the year 1985, the propor-
tion rose to 31% by 1998, and this trend is expected to continue [9].
4. Cost of management of cardiovascular disease in Africa
In Africa, the cost of management is variable. With regard to hypertension, the 
overall average daily cost of drug treatment for uncomplicated hypertension is esti-
mated at 368 ± 234.6 FCFA, i.e. 0.68 ± 0.44 dollars, representing more than a third 
of the daily income (1.90 dollars) [11]. In view of the cost of treatment, the absence 
of symptoms associated with hypertension is often the cause of non-adherence to 
treatment. Also, some patients who often reach the stages of complications of CVDs 
often experience the cost of treatment increased by the additional cost of treating the 
associated complications [12].
In Africa, 60–70% of health expenditure is paid by households directly to 
health facilities, compared to a global average of 46%. This may be due to the pre-
ponderance of the informal sector (farmers, craftsmen,…) which groups together 
more than 70% of the African population who are not covered by health insurance. 
Contrary to those in the informal sector, some African governments are setting 
up compulsory health insurance systems for the formal sector, civil servants 
or employees of private companies, financed through employee and employer 
contributions [13].
5. Poverty, malnutrition and cardiovascular disease: a vicious cycle
Poverty is one of the socio-economic factors at the root of malnutrition in 
Africa. The prevalence of malnutrition in SSA rose from 181 million in 2010 to 222 
million in 2016 [14]. Poverty and malnutrition are part of a vicious circle. Poverty 
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leads to malnutrition, especially maternal malnutrition, which causes low birth 
weight, stunted infants and adolescents. These individuals will be disadvantaged 
later in life because they may show a reduction in physical and mental development 
leading to low skills and reduced human capital. Competence is one of the facul-
ties developed through adequate nutrition of children and adolescents. Wachs has 
defined competence as the ability to adapt and interact with one’s environment 
[15]. Human capital refers to well-nourished, healthy, educated, skilled and alert 
individuals - an improved human condition - resulting in a workforce that could be 
the most productive asset of any country. However, the absence of this productivity, 
particularly economic productivity, perpetuates poverty [16]. Alongside poverty, 
we also have a trend towards the Westernization of the African lifestyle, which is 
not the least compounding factor for the emergence of CVDs in Africa.
The African population is experiencing an increasing rate of urbanization, 
with a shift in migration from rural to urban areas, with changes in lifestyle habits 
in particular, as the traditional diet rich in fruits and vegetables is gradually being 
replaced by a diet rich in calories densed foods from snacks, sweetened beverages, 
animal fats and low in complex carbohydrates. This change in diet is accompanied 
by weight gain (overweight and obesity) and a decrease in physical activity due 
to the abolishment of traditional agriculture for sedentary work [9]. This change 
in lifestyle is contributing to an increase in the prevalence of cardiovascular risk 
factors in Africa, with a tendency to equalize the prevalence in high-income coun-
tries. The prevalences of some cardiovascular risk factors in SSA are given below 
in comparison with high-income countries (HICs): Smoking rates are 10% in SSA 
versus 30% in HIC; hypertension prevalence in individuals ≥18 years old is 30% in 
SSA (40% in urban and 20% in rural populations) versus 20% in HIC; diabetes mel-
litus prevalence in persons aged above 17 years is 7.1% in adult males and females 
in SSA compared with up to 8% in males and up to 6% in women in HIC. Also, 
dyslipidemia prevalence in adults is 25% in SSA versus 40–60% in HICs; physical 
inactivity prevalence is 22% in SSA versus 29–40% in HIC; and obesity whose 
prevalence rates are variable in SSA and higher among women (2–40%) compared 
with men (1–15%) versus 18–35% in women and 12–30% among men in HIC [17]. 
Poverty has several consequences, including the development of communicable and 
non-communicable diseases.
In the 1980s, a real revolution in the understanding of chronic diseases in adults was 
initiated with the pioneering work of an English epidemiologist named David Barker. 
During an observational study, he found that regions of UK that had a high rate of 
cardiovascular mortality, also had a high infant mortality rate [18]. Then a meticulous 
study of patients with NCDs [18], allowed him to put forward a hypothesis on the 
“origin of the development of health and disease” or early origin of adult diseases 
based on the premise that environmental factors during foetal life have a considerable 
impact on the susceptibility to various pathologies later in life of these exposed persons 
[18]. More precisely; malnutrition occuring in utero permanently changes the body’s 
structure and function in ways that “programme” the appearance of disease in child-
hood, adolescenthood or adulthood [18].
At present it has been recognized that malnutrition during pregnancy is the 
cause of an alteration in the fetus in the short term of the programmed metabolism 
of carbohydrates and lipids and of the functions of the genes. In the long term, 
these changes will lead to reduced cognitive development, decreased educational 
performance, compromised immunity, lower physical capacity and an increased 
risk of several NCDs [18–21]. The physiopathological mechanisms by which 
foetal malnutrition can lead to NCDs are better elucidated to date. Gluckman and 
collaborators have shown that malnutrition is responsible for a modification of 
gene expression via epigenetic modification by methylation of foetal DNA. They 
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hypothesized that the changed genetic expression may change physiological set 
points that will eventually change the way individuals respond to environmental 
exposures later on their lives [22]. The management of CVDs management leads to 
direct and indirect costs, thus perpetuating the vicious circle of poverty.
Direct costs are related to chronic diseases and these costs entail the direct 
payment by patients for cardiovascular healthcare services, cardiovascular 
investigation tests (12-led electrocardiogram, Holter electrocardiogram, stress 
electrocardiogram, heart ultrasound, transesophageal ultrasound) and medications 
for CVDs. Patients with CVDs are often confronted with a dilemma: to suffer and 
possibly die without treatment, or to seek treatment and drag their families into 
poverty. The situation is particularly serious for people with long-term chronic 
CVDs such as chronic heart failure, stroke survivals with significant physical dis-
abilities because the costs of medical care is often life-long and relatively expensive. 
Indirect costs are a reduction in income subject to illness due to loss of productivity 
resulting from illness or death; the cost of time spent by adult members of the 
family household caring for those who are ill. There is also the loss of income that 
will result from the sale of goods necessitated by the need to meet direct costs and 
unpredictable expenses, and the missed opportunities for children who are forced 
to give up school to care for sick adults or contribute to the family economy [21]. 
Hence, CVDs will not only have a detrimental effect on the income of the patients 
with CVDs, but also on that of the family; subsequently, there will be with a marked 
pejorative impact on the economy of different African nations resulting in a drop in 
the economy of the African continent.
6.  Prevention of cardiovascular diseases and insurance health system of 
African countries
6.1 Prevention of cardiovascular diseases
According to the WHO, primary prevention of CVDs is defined as measures 
put in place to decrease the incidence of cardiovascular events (ischaemic heart 
disease and strokes) in individuals at risk of CVDs who have not yet developed 
overt or clinical CVDs. Efforts geared at preventing recurrent clinical cardiovascu-
lar events in individuals with CVDs are called secondary prevention [22]. Reports 
have shown the beneficial impacts of pharmacological interventions in primary 
and secondary the prevention of CVDs, though with caveats for population-based 
interventions. The need for economic assessment of these studies to identify those 
which have best value for money is paramount in inform decision making by health 
policy makers in designing a health system insurance policy [23]. Furthermore, 
WHO projects that by 2030, NCDs will overtake all other causes of mortality in 
all Africa [24]. With the increasing CVDs burden in Africa, the AHN was created 
in 2001. The AHN is a joint collaboration of various cardiovascular societies and 
national heart foundations sharing the same agenda: curbing CVDs in Africa, 
thereby improving the cardiovascular health for all Africans. The vision of the 
AHN is to play a leading role in the prevention and reduction of the burden related 
to CVDs, including cerebrovascular accident to halt from no longer being the major 
etiology of disability and premature death in the African continent. The AHN 
shares the vision of the World Heart Federation (WHF), the main organization of 
national and continental cardiovascular societies and foundations globally. The 
WHF’s global target of ‘25 by 25’ represents the objective of decreasing premature 
deaths caused by CVDs by 25% by the year 2025—an interim goal addressed by the 
Sousse’ Declaration of 2018 [25]. The objective of the AHN held in Tunisia in 2018 
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was on the prevention of CVDs. The conference was endorsed by the Minister of 
Health of Tunisia, highlighting the importance of governmental collaborations in 
attending ‘health-for-all’. Themes arising from the conference included the man-
agement of various cardiovascular risk factors, legislation of these cardiovascular 
risk factors, and using the leverage of other local and international organizations 
to improve cardiovascular health in Africa. Cited cardiovascular risk factors to be 
urgently cared for in Africa include diabetes mellitus, hypertension and dyslipi-
daemia. There is therapeutic inertia in the therapeutic algorithms of these condi-
tions especially hypertension. The AHN emphasized on the importance of the 
timely treatment of resistant hypertension. Obesity was highlighted as the main 
driver of the diabetes epidemic in Tunisia as well as Africa, with 75% of patients 
with Type 2 diabetes mellitus dying from CVDs. A 1% improvement in glycosyl-
ated hemoglobin was shown to decrease mortality from ischemic heart disease by 
more than 14% in the Tunisian population although glycemic control is not often 
achieved in the African continent due to low awareness, treatment and control 
of diabetic patients who often present late with acute complications of diabetes 
mellitus such as hyperglycemic comas. Various barriers to control had been identi-
fied, namely the inability of clinicians to apply treatment guidelines, inadequate 
monitoring or surveillance of blood pressure and glycaemia, lack of community 
education and empowerment, and most importantly, the cost of accessing health-
care. There is also a poor awareness of the cardiovascular risks associated with 
dyslipidemia in SSA. The South African perspective displayed an increase in the 
burden of dyslipidemia due to anti-retroviral therapy (ART) induced dyslipidemia 
in patients living with HIV/AIDS and treated with ART. This needs to be promptly 
managed in order to prevent CVDs. Previous studies have identified the huge 
burden of premature ischemic heart disease partly due to dyslipidemia in Africa 
compared to other regions [26]. This reflects a lack of prevention, early detection 
and effective management of CVDs in Africa. Preventing CVDs remains a major 
challenge for development within the region as it results in significant health, 
financial and social consequences for individuals and government. Likewise, the 
control of tobacco use, known a risk factor of six of the eight leading causes of 
CVDs death was highlighted as being important. The role of healthcare provid-
ers and health authorities in preventing CVDs due to tobacco use was addressed 
through a governmental vote on the increment of tobacco taxation as there remains 
a discrepancy between taxes paid and the treatment cost of tobacco related health 
disease and death. The WHO ‘MPOWER’ package was emphasized as a tool to 
assist countries with tobacco reduction measures. In addition, patients should be 
motivated by clinicians and family members to quit smoking with both counseling 
and the early use of pharmacotherapy. In the same vein, the formulation of legisla-
tions to control cardiovascular risk factors including the control intervention for 
the effective implementation of physical exercise and encouraging a low-calorie 
dense foods to prevent CVDs mortality related to obesity and diabetes mellitus are 
strongly recommended. This will however, require an involvement from policy 
makers for the formulation of public health interventions geared at curbing the 
burden of CVDs in Africa. Moreover, there is a shortage in drugs and equipment 
for monitoring CVDs between African countries which needs to be addressed 
for CVDs prevention. This is due to preference in healthcare expenditures for 
infectious diseases at the detriment of CVDs in Africa. Various partnerships 
including the WHF, the United Nations the Non-communicable disease alliance 
(NCD Alliance), Pan African Society of Cardiologists (PASCAR), American Heart 
Association (AHA), Medtronic Foundation, Heart and Stroke Foundation of South 
Africa, World Heart Day events, The Kenyan-Heart Talking Walls project are 
key continental and inter-continental foundations trying to achieve and prevent 
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cardiovascular health for all in Africa. Also, the social media is a crucial platform 
to increase awareness in communities regarding CVDs awareness and prevention. 
Successful CVDs preventive interventions such as the RESOLVE and the WHO 
Global Hearts projects need to be taken by African Stakeholders to improve car-
diovascular health by addressing important issues such as improved management 
of hypertension, decreasing salt intake and tobacco use. It is worth to mention 
that CVDs prevention in Africa can significantly be achieved by identifying health 
advocates as well as effective leadership and the coalition of professional groups. 
Hence, an ‘Africa-specific’ guidelines for CVDs prevention need to be formulated 
and adopted. CVD risk factors prevention in Africa cannot be overemphasized as 
cardiac surgery to amend cardiovascular diseases still remain expensive and scarce 
in a continent already overburdened with poverty.
The International Forum for Hypertension Control and Prevention in Africa 
formulated treatment guidelines for CVDs prevention in 2003 [27]. Since then, 
CVDs preventive interventions to identify cardiovascular risk factors and set guide-
lines are now under way. Some African countries have conducted epidemiological 
studies, a few have begun to continually monitor and assess their programmes, and 
others, Nigeria and South Africa, have their own guidelines for managing hyperten-
sion. There is hope though, and some attention has finally been focused on CVDs 
prevention in Africa. However, challenges such as poor healthcare infrastructure, 
underfunded and understaffed health systems in Africa, inadequate access to cheap 
generic drugs and lack of public recognition and acceptance of the importance of 
CVDs will continue to hinder the effective implementation of both population-
based health programmes and those aimed at people at high CVDs risk [28, 29]. The 
continent’s people need education on healthier lifestyles such as weight reduction, 
smoking cessation, and greater physical activity.
6.2 Insurance health system of African countries
CVDs are very burdensome to manage in Africa due to a lack of a national 
health insurance policy in most SSA countries [30]. Health systems insurance is 
primordial for achieving universal healthcare by providing financial protection to 
patients. It helps protect people from high healthcare costs by pooling funds to allow 
a cross-subsidization between the rich and poor and between the healthy and the 
sick [31]. Healthcare insurance coverage is still inexistent or at an embryonic stage 
in most African countries. This has largely contributed to poverty, poor cardiol-
ogy service delivery and mortality from CVDs in Africa. Implementing an African 
health system insurance remains an important goal to improve the health status of 
individuals in Africa [4]. Reports illustrates that in the several SSA countries, direct 
out-of-pocket payments as a share of total health expenditure are still above 40%, 
exorbitantly high above WHO 20% threshold level of the total health expenditure 
below which financial risk protection can be ensured, and thus leading to poverty 
in Africa [32]. There is a serious handicapping sparsity of health systems insurance 
in most African nations where only about 15% of the 55 countries have national 
comprehensive health insurance schemes [33]. Evidence abounds that in SSA, the 
poor bear the highest burden of diseases and subsequently, experience very high 
expenses on healthcare costs [34]. Hence, the development of a health system insur-
ance scheme should be advocated in public health and financial planning within 
African countries for better healthcare delivery in general. A universal healthcare 
system with national-level health insurance scheme would probably be more effica-
cious to avoid the low-socioeconomic class of the population from being marginal-
ized. Strategies such as compulsory taxations from employees, deductions from 
sales taxes, and an increment on tobacco taxes have been shown to be effective in 
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some countries in SSA [35] .A comparative study of five African countries (Ghana, 
Tanzania, Kenya, Rwanda and Ethiopia) sought to help fill this gap by looking at 
how a national health system insurance schemes can cover the poor or not, as the 
case may be. Selected countries had were national insurance schemes with the intent 
of providing health insurance for all their inhabitants. Ghana, Kenya and Tanzania 
had similar health insurance programmes [36–40]. Ghana’s National Health 
Insurance Scheme (NHIS), covers every citizen by law. Tanzania and Kenya had 
separate insurance schemes for the public and private sectors. Rwanda and Ethiopia 
operated a Community-Based Health Insurance (CBHI), but Rwanda’s CBHI was the 
only one with wide coverage of the poor. Hence, setting down insurance policies or 
programmes does not guarantee reaching the poor. Many have questioned whether 
African countries have been too eager to adopt Western-style policies that are not 
necessarily appropriate to their context-specific fiscal laws. The selected countries 
are characterized by large informal sectors, making it difficult for the rolling out of 
health insurance scheme models that depend on this group. After almost 12 years 
of introducing national health insurance in Ghana, less than 40% of the population 
were covered by the health system insurance scheme. In spite of provisions made 
to cover the poor, health system insurance programmes have faced challenges in 
enrolling this group. Defining who the poor are is a task that policymakers have 
grappled with. Many terms have been used to identify the poor—ultrapoor, very 
poor, indigent and vulnerable. Coining these terms and explaining what they mean 
and who qualifies to be categorized as such has become not only burdensome but 
costly—and political [41].
The way forward to establishing a sustainable cost-effective and context specific 
health system insurance scheme in SSA should take into consideration the following. 
Firstly, the fact that the educational and socioeconomic status of a family play key 
roles in the decision of whether to enroll in health insurance should take into consid-
eration that community-based health insurance provides some financial protection 
by reducing out-of-pocket spending [42]. Secondly, data analysis from micro-level 
household indicates that community financing improves access by rural and private 
sector workers to needed heath care and provides them with some financial protec-
tion against the cost of illness. Thirdly, analysis from macro-level cross-country gives 
empirical support to the hypothesis that risk-sharing in health financing matters in 
terms of its impact on both the level and distribution of health, financial fairness and 
responsiveness indicators [43].
7. Conclusion
In view of the vicious circle of poverty, lifestyle and cardiovascular disease 
in Africa, we propose some solutions to break this cycle. Women of childbearing 
age need to be well nourished, empowered and educated. They are “the most 
proximal levers” on which we can act to ensure optimal foetal and infant nutri-
tion to break the vicious circle of poverty; malnutrition, underdevelopment and 
non-communicable disease. Obstacles hampering primary and secondary preven-
tion of CVDs in SSA such as insufficient health care systems and infrastructure, 
scarcity of cardiologists, skewed budget allocation and disproportionate pri-
oritization away from NCDs, high cost of cardiac treatments and interventions 
coupled with rarity of health insurance systems in most African countries need 
to be urgently addressed by the various governments and ministries of health of 
different African countries.
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